COST PLUS FIXED FEE

ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC. - A PHASE 1 TRIAL TO EVALUATE AN ORALLY INGESTED PROBIOTIC YEAST GENETICALLY MODIFIED TO EXPRESS A TETRA-SPECIFIC ANTI-TOXIN FOR CLOSTRIDIOIDES DIFFICILE

PIID: 75N93025F00001

Signed Date: Jan 23, 2026Effective Date: Jan 14, 2022End Date: Closes in 740 days

Award $

$2.5M

Vendor

ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.

NAICS

541715

Signed Date

Jan 23, 2026

Key Details

Dollars Obligated

$2.5M

Base & All Options

Awarding Agency

Department of Health and Human Services

Awarding Sub-Agency

National Institutes of Health

NAICS Code

541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)

Product Service Code

AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

BLUE BELL, PA, 194221230, CD-PA-04

Description

A PHASE 1 TRIAL TO EVALUATE AN ORALLY INGESTED PROBIOTIC YEAST GENETICALLY MODIFIED TO EXPRESS A TETRA-SPECIFIC ANTI-TOXIN FOR CLOSTRIDIOIDES DIFFICILE

Context & Analysis

On Jan 23, 2026, Department of Health and Human Services obligated $2,514,022 to ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC. for a phase 1 trial to evaluate an orally ingested probiotic yeast genetically modified to express a tetra-specific anti-toxin for clostridioides difficile. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost plus fixed fee contract. Competition extent: full and open competition with 1 offer received. Performance is located in BLUE BELL, PA. The contract is scheduled through Sep 21, 2028. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.